Cargando…

A Non-invasive Digital Biomarker for the Detection of Rest Disturbances in the SOD1G93A Mouse Model of ALS

Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease that affects both central and peripheral nervous system, leading to the degeneration of motor neurons, which eventually results in muscle atrophy, paralysis, and death. Sleep disturbances are common in patients with ALS,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golini, Elisabetta, Rigamonti, Mara, Iannello, Fabio, De Rosa, Carla, Scavizzi, Ferdinando, Raspa, Marcello, Mandillo, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490341/ https://www.ncbi.nlm.nih.gov/pubmed/32982678 http://dx.doi.org/10.3389/fnins.2020.00896

Ejemplares similares

Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
por: Golini, Elisabetta, et al.
Publicado: (2023)

Prolonged Voluntary Running Negatively Affects Survival and Disease Prognosis of Male SOD1G93A Low-Copy Transgenic Mice
por: Garbugino, Luciana, et al.
Publicado: (2018)

Data repurposing from digital home cage monitoring enlightens new perspectives on mouse motor behaviour and reduction principle
por: Fuochi, Sara, et al.
Publicado: (2023)

Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene
por: Cardinali, Beatrice, et al.
Publicado: (2021)

Towards large scale automated cage monitoring – Diurnal rhythm and impact of interventions on in-cage activity of C57BL/6J mice recorded 24/7 with a non-disrupting capacitive-based technique
por: Pernold, Karin, et al.
Publicado: (2019)

Microglia Morphological Changes in the Motor Cortex of hSOD1(G93A) Transgenic ALS Mice
por: Migliarini, Sara, et al.
Publicado: (2021)

A closer look at the SOD1(G93Adl) mouse model of ALS
Publicado: (2011)

Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012)

Connexin 30 deletion exacerbates cochlear senescence and age-related hearing loss
por: Paciello, Fabiola, et al.
Publicado: (2022)

Circulating myomiRs in Muscle Denervation: From Surgical to ALS Pathological Condition
por: Casola, Irene, et al.
Publicado: (2021)

A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing
por: Scavizzi, Ferdinando, et al.
Publicado: (2021)

Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing
por: Lupini, Laura, et al.
Publicado: (2022)

Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS
por: Apolloni, Savina, et al.
Publicado: (2019)

Effects of RAGE inhibition on the progression of the disease in hSOD1(G93A) ALS mice
por: Liu, Liping, et al.
Publicado: (2020)

Cortical glia in SOD1(G93A) mice are subtly affected by ALS-like pathology
por: Filipi, Tereza, et al.
Publicado: (2023)

Antibody gene transfer treatment drastically improves epidermal pathology in a keratitis ichthyosis deafness syndrome model using male mice
por: Peres, Chiara, et al.
Publicado: (2023)

The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice
por: Valsecchi, Valeria, et al.
Publicado: (2020)

ALS-associated mutant SOD1(G93A )causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes
por: Higgins, Cynthia MJ, et al.
Publicado: (2003)

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1(G93A) Mice Predates Disease Onset and Is A Promising Therapeutic Target
por: Scaricamazza, Silvia, et al.
Publicado: (2020)

Increased Orexin Expression Promotes Sleep/Wake Disturbances in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
por: Liu, Rong, et al.
Publicado: (2015)

Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
por: Marc, Gotkine, et al.
Publicado: (2013)

Electrophysiologic Biomarkers for Assessing Disease Progression and the Effect of Riluzole in SOD1 G93A ALS Mice
por: Li, Jia, et al.
Publicado: (2013)

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression
por: Apolloni, Savina, et al.
Publicado: (2016)

Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model
por: Spalloni, Alida, et al.
Publicado: (2019)

The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
por: Nowicka, Natalia, et al.
Publicado: (2022)

Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography
por: Nagy, Janice A., et al.
Publicado: (2022)

Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice
por: Bertin, Eléonore, et al.
Publicado: (2022)

Oral D-Aspartate Treatment Improves Sperm Fertility in Both Young and Adult B6N Mice
por: Raspa, Marcello, et al.
Publicado: (2022)

Calcium Signaling in the Photodamaged Skin: In Vivo Experiments and Mathematical Modeling
por: Donati, Viola, et al.
Publicado: (2021)

Microglia modulate hippocampal synaptic transmission and sleep duration along the light/dark cycle
por: Corsi, Giorgio, et al.
Publicado: (2021)

Neuromuscular effects of G93A-SOD1 expression in zebrafish
por: Sakowski, Stacey A, et al.
Publicado: (2012)

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods
por: Vinsant, Sharon, et al.
Publicado: (2013)

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion
por: Vinsant, Sharon, et al.
Publicado: (2013)

Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
por: Gotkine, Marc, et al.
Publicado: (2015)

Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
por: Yan, Lina, et al.
Publicado: (2018)

Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1(G93A)) of ALS
por: Chiarotto, Gabriela Bortolança, et al.
Publicado: (2019)

Time Course of Alterations in Adult Spinal Motoneuron Properties in the SOD1(G93A) Mouse Model of ALS
por: Huh, Seoan, et al.
Publicado: (2021)

Locus-specific analysis of Transposable Elements during the progression of ALS in the SOD1(G93A) mouse model
por: Valdebenito-Maturana, Braulio, et al.
Publicado: (2021)

Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1(G93A) ALS Mice
por: Gaja-Capdevila, Núria, et al.
Publicado: (2021)

Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1(G93A) ALS mouse model
por: Zhang, Haoyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hbm44r909cjsff7n97nirb09df